Cyril Konto
- Role
- President and Chief Executive Officer at Igi
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
About Cyril Konto
Cyril Konto is an experienced physician-scientist with a proven track record in advancing…
Experience
President and Chief Executive Officer
May 2021 — Present
Ichnos is a NYC-based spin-off of Glenmark Pharmaceuticals. It was born out of Glenmark\'s innovative R&D at its research center for biologics in Switzerland. Ichnos clinical research pipeline includes three new biological entities for oncology and autoimmune diseases. Drug candidates are designed with the company\'s proprietary BEAT® (Bispecific Engagement by Antibodies based on the T cell receptor) platform.
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.